Lyell Immunopharma (LYEL) P/E Ratio
P/E Ratio as of Jun 13, 2025: -0.39
Average-0.3790
Median-0.3400
Minimum-0.5400
Maximum-0.3200
-0.39
Past Month-0.07 (21.88%)
The P/E ratio for Lyell Immunopharma (LYEL) is -0.39 as of Jun 13, 2025. This represents a decrease of -61.76% compared to its 12-month average P/E ratio of -1.02. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Lyell Immunopharma P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Lyell Immunopharma’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Lyell Immunopharma to industry peers.
Lyell Immunopharma P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Lyell Immunopharma’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Lyell Immunopharma to industry peers.
Lyell Immunopharma (LYEL) P/E Ratio Insights
See Lyell Immunopharma’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in Lyell Immunopharma (LYEL)
Order type
Buy in
Order amount
Est. shares
0 shares
Lyell Immunopharma (LYEL) P/E Ratio Historic Data
| Date | Stock price | P/E ratio |
|---|---|---|
| Jun 2, 2025 | $8.22 | -0.33 |
| May 1, 2025 | $9.40 | -0.38 |
| Apr 1, 2025 | $9.686 | -0.39 |
| Mar 3, 2025 | $13.228 | -0.50 |
| Feb 3, 2025 | $11.69 | -0.45 |
| Jan 2, 2025 | $12.90 | -0.49 |
Lyell Immunopharma (LYEL) End of Year P/E Ratio
| Date | P/E ratio | Change |
|---|---|---|
| 2025 | -0.39 | -20.41% |
| 2024 | -0.49 | -80.78% |
| 2023 | -2.55 | -22.49% |
| 2022 | -3.29 | -56.02% |
| 2021 | -7.48 | — |
FAQs About Lyell Immunopharma (LYEL) P/E ratio
The latest P/E ratio of Lyell Immunopharma (LYEL) is -0.39, as of Jun 13, 2025. This is calculated based on its current stock price and earnings per share (EPS).
Lyell Immunopharma’s last 12-month average P/E ratio is -1.02, compared to its current P/E ratio of -0.39. This reflects a decrease of -61.76%.
Lyell Immunopharma’s current P/E ratio of -0.39 is lower than its last 12-month average P/E of -1.02. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Lyell Immunopharma’s average P/E ratio over the last 3 years is -2.86. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Lyell Immunopharma’s average P/E ratio over the last 5 years is -2.4. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.